BioSpace News Archive

Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with Nielsen BioSciences, Inc. (Nielsen), a privately-held biopharmaceutical company based in San Diego, CA, to study the safety and efficacy of CANDIN® for the treatment of common warts.

Alcanza Clinical Research, mission-driven investigator site network, announced today a strategic partnership with Reveles, a provider of equity-driven decentralized clinical trials.

Agendia, Inc., a gene expression profiling company advancing personalized early-stage breast cancer care, announced the appointment of industry veterans Ronald Andrews and David Schreiber to the company’s Board of Directors.

Toronto, Ontario--(Newsfile Corp. - June 13, 2023) - Neural Therapeutics Inc. (the “Company” or “Neural”) an ethnobotanical drug-discovery and development company announces it is undertaking a rights offering to raise gross proceeds of up to $1,184,080 (the “Rights Offering”) and a non-brokered private placement of up to $900,000 (“Concurrent Private Placement”).

A devastated mother from Vermont has revealed how a common cough led to her baby being diagnosed with a rare, incurable and deadly disease.

ERYTECH Pharma, announced that the Lyon Commercial Court has rejected Akkadian’s request to postpone the vote on the merger with Pherecydes Pharma.

Avid Bioservices, Inc. announced that it will report financial results for the quarter and fiscal year ended April 30, 2023 on June 21, 2023, after market close and will host a webcast at 1:30 PM Pacific Time.

BIOLASE, Inc., the global leader in dental lasers, announced that President and Chief Executive Officer, John Beaver and Chief Financial Officer, Jennifer Bright, have been invited to participate in the 2023 Virtual Healthcare Conference, presented by Maxim Group LLC and hosted by M-Vest, on June 20th to 22nd.

Biocept, Inc. (Nasdaq: BIOC) (“Biocept” or the “Company”), a leading provider of molecular diagnostic assays, products and service, announces that management will present at the Maxim Group Virtual Healthcare Conference hosted by M-Vest on Tuesday, June 20 at 9:00 a.m. Eastern time (6:00 a.m. Pacific time).

Amsterdam, the Netherlands – Royal Philips announced that it will repurchase up to 7.1 million shares to cover certain of its obligations arising from its long-term incentive plans.